st 1435 has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akwa, Y; El-Etr, M; Rame, M; Schumacher, M; Sitruk-Ware, R | 1 |
| Brinton, RD; Chen, S; Kumar, N; Mao, Z; Sitruk-Ware, R | 1 |
| Ogaeri, T; Samsonov, M; Sokabe, M; Tanaka, M | 1 |
| De Nicola, AF; Garay, L; Gonzalez Deniselle, MC; Guennoun, R; Meyer, M; Schumacher, M; Sitruk-Ware, R | 1 |
4 other study(ies) available for st 1435 and Disease Models, Animal
| Article | Year |
|---|---|
Nestorone
Topics: Animals; Demyelinating Diseases; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Myelin Sheath; Norprogesterones; Remyelination | 2021 |
Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain.
Topics: Aging; Analysis of Variance; Animals; Cell Proliferation; Cell Survival; Cognitive Dysfunction; Disease Models, Animal; Drug Discovery; Drug Therapy, Combination; Estradiol; Female; Frontal Lobe; Hippocampus; Infusions, Subcutaneous; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Neural Stem Cells; Neurodegenerative Diseases; Neurogenesis; Norprogesterones; Oligodendroglia; Regeneration | 2018 |
Nestorone exerts long-term neuroprotective effects against transient focal cerebral ischemia in adult male rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Neuroprotection; Neuroprotective Agents; Norprogesterones; Progesterone; Rats; Rats, Sprague-Dawley; Stroke | 2019 |
The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Disease Models, Animal; Gliosis; Male; Mice, Mutant Strains; Microglia; Motor Neuron Disease; Motor Neurons; Neuroimmunomodulation; Neuroprotective Agents; Norprogesterones; Receptors, Progesterone; Spinal Cord; Treatment Outcome | 2015 |